The Journal invites manuscripts on all aspects of the various types of extracellular vesicles, including, but not limited to: the biology of their production; structure; function; applications in medicine, therapy and diagnosis (as biomarkers); and new techniques – a broad-based theme that should appeal to the largest possible audience interested in this subject.
We will be publishing a significant number of high-quality original research articles and scientific reviews from authors around the world. The Journal has a strong belief in the impact both positive and negative data can have on scientific research, so actively encourages the submission of both. We are confident that the Journal will fulfil the role of a mainstream open-access international journal in this ever-expanding area of research, serving the best interests of the scientific community worldwide, while providing a complete, reliable and freely-available source of information and essential reading on current developments in the field.
The cost of publishing an article to a publisher is extensive – from the stage of receiving a manuscript to its evaluation, typesetting, copy-editing, proof-reading, digitisation, database indexing, and making it available online. Conventional publishers cover these costs through sales and subscriptions, which is not possible for open-access publishers. Thus, they charge a publication fee (open-access fee/OAF). However, this is not a direct burden on the authors’ actual research grant or their personal funds, as several funding bodies now allow additional funds for publishing in open access journals.
As a publisher, we have traditionally kept our publication fees low for our journals, as we have been fortunate enough to have the support of colleagues from academia and industry to help us with some stages of publishing. We pass on these savings to our authors. We also help authors from developing countries by partial or full waiver of the OAF. We will keep this theme going for EJEV! In fact, we will not charge any publication fee for the first 25 articles published in the Journal, as long as the articles are prepared according to the instructions for authors and within the recommended word limits.
As well as giving free, unrestricted access to the published content via the Journal website, and via permanent digital archives, such as PubMed Central and the Directory of Open Access Journals, we plan to index the journal in several key scholarly databases, including PubMed/Medline, Biological Abstracts, SCOPUS, Google Scholar, CAS, NextBio and many others. This is aligned with our aspirations and policy to support open-access content, and to give authors and their research high global visibility among their peers.
We very much look forward to your support this exciting new venture and welcome any comments or suggestions you may have to improve the Journal.